GlassScriptPhysician profile
Andrew J Johnson
NPI 1326255449
$2,596.10
in general payments reported to CMS, 2019-2025
16 companies · $672 in 2025
The $672 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.85 · 2022: $163 · 2023: $26.32 · 2024: $1,721 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927 · Travel and Lodging: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.29 |
| Travel and Lodging | $491.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $894.32 | 2024-2025 | Vyepti |
| Pacira Pharmaceuticals Incorporated | $598.06 | 2023-2024 | Iovera |
| Stratus Medical, LLC | $190.53 | 2024 | Nimbus |
| Globus Medical, INC. | $166.64 | 2025 | Senza |
| Abbvie INC. | $124.38 | 2024 | |
| Avanos Medical | $101.64 | 2024 | Coolief* Cooled Radiofrequency |
| Spr Therapeutics, INC | $95.85 | 2022 | |
| Pfizer INC. | $90.42 | 2024 | |
| Tonix Medicines, INC. | $77.10 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $74.73 | 2025 | |
| Acacia Pharma INC | $47.24 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $42.36 | 2024-2025 | Ajovy |
| Stryker Corporation | $29.60 | 2024 | Spinejack |
| Lilly USA, LLC | $26.99 | 2021-2024 | Emgality, Reyvow |
| Upsher-Smith Laboratories LLC | $20.14 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $16.10 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.